The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma

Virchows Archiv

Volumn 467, Issue 2, 2015, Pages 217-224

  Thway, Khin ^a   Wang, Jayson ^b   Wren, Dorte ^c   Dainton, Melissa ^c   Gonzalez, David ^c   Swansbury, John ^c   Fisher, Cyril ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Alveolar rhabdomyosarcoma; Fluorescence in situ hybridization; Molecular diagnostics; Reverse transcription polymerase chain reaction; Sarcoma

Indexed keywords

TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; ONCOPROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; PAX3-FOXO1A FUSION PROTEIN, HUMAN; PAX7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR PAX7;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SIZE; CHILD; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SMALL CELL SARCOMA; COMPARATIVE STUDY; GENETICS; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; RHABDOMYOSARCOMA, ALVEOLAR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; PAX7 TRANSCRIPTION FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA, ALVEOLAR; YOUNG ADULT;

EID: 84938960868     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-015-1777-9     Document Type: Article

References (40)

1. Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the U.S. Cancer 78:532–541
2. Tsokos M (1994) The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 11:26–38
3. Crist WM, Garnsey L, Beltangady MS et al (1990) Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 8:443–452
4. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14:506–514
5. Antonescu CR (2006) The role of genetic testing in soft tissue sarcoma. Histopathology 48:13–21
6. Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E (1986) Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 19:361–362
7. Biegel JA, Meek RS, Parmiter AH, Conard K, Emanuel BS (1991) Chromosomal translocation t(1;13)(p36;q14) in a case of rhabdomyosarcoma. Genes Chromosomes Cancer 3:483–484
8. Galili N, Davis RJ, Fredericks WJ et al (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5:230–235
9. Davis RJ, D’Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54:2869–2872
10. Bridge JA, Liu J, Qualman SJ et al (2002) Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33:310–321
11. Nishio J, Althof PA, Bailey JM et al (2006) Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest 86:547–556
12. Downs-Kelly E, Shehata BM, Lopez-Terrada D et al (2009) The utility of FOXO1 fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded specimens in the diagnosis of alveolar rhabdomyosarcoma. Diagn Mol Pathol 18:138–143
13. Harms D (1995) Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol 89:273–296
14. Williamson D, Missiaglia E, de Reynies A et al (2010) Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 28:2151–2158
15. Parham D, Barr FG (2013) Alveolar rhabdomyosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone, 4th edn. IARC Press, Lyon, pp 130–132
16. Bijwaard KE, Fetsch JF, Przygodzki R, Taubenberger JK, Lichy JH (2002) Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction. J Mol Diagn 4:59–64
17. Hostein I, Andraud-Fregeville M, Guillou L et al (2004) Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens. Cancer 101:2817–2824
18. Gordon A, McManus A, Anderson J et al (2002) Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case. Cancer Genet Cytogenet 140:73–77
19. Fisher C (2010) Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch 456:153–166
20. Douglass EC, Valentine M, Etcubanas E et al (1987) A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45:148–155
21. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T (1992) Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer 5:299–310
22. McManus AP, O’Reilly MA, Jones KP et al (1996) Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma—a diagnostic tool in minimally invasive biopsies. J Pathol 178:410–414
23. Reichmuth C, Markus MA, Hillemanns M et al (1996) The diagnostic potential of the chromosome translocation t(2;13) in rhabdomyosarcoma: a PCR study of fresh-frozen and paraffin-embedded tumour samples. J Pathol 180:50–57
24. Hill DA, O’Sullivan MJ, Zhu X et al (2002) Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol 26:965–977
25. Thway K, Rockcliffe S, Gonzalez D et al (2010) Utility of sarcoma-specific fusion gene analysis in paraffin-embedded material for routine diagnosis at a specialist centre. J Clin Pathol 63:508–512
26. Tanas MR, Rubin BP, Tubbs RR, Billings SD, Downs-Kelly E, Goldblum JR (2010) Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience. Arch Pathol Lab Med 134:1797–1803
27. Parham DM, Qualman SJ, Teot L et al (2007) Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. Am J Surg Pathol 31:895–901
28. Treetipsatit J, Kittikowit W, Zielenska M, Chaipipat M, Thorner PS, Shuangshoti S (2009) Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review. Pediatr Dev Pathol 12:383–389
29. Neuville A, Ranchere-Vince D, Dei Tos AP et al (2013) Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. Am J Surg Pathol 37:1259–1268
30. Downing JR, Khandekar A, Shurtleff SA et al (1995) Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing’s sarcoma. Am J Pathol 146:626–634
31. Barr FG, Chatten J, D’Cruz CM et al (1995) Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273:553–557
32. Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol 20:2672–2679
33. Stegmaier S, Poremba C, Schaefer KL et al (2011) Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS). Pediatr Blood Cancer 57:406–414
34. Kelly KM, Womer RB, Sorensen PH, Xiong QB, Barr FG (1997) Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15:1831–1836
35. Missiaglia E, Williamson D, Chisholm J et al (2012) PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 30:1670–1677
36. Davicioni E, Anderson JR, Buckley JD, Meyer WH, Triche TJ (2010) Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children’s oncology group. J Clin Oncol 28:1240–1246
37. Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ, Anderson MJ (2006) Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66:6936–6946
38. Walters ZS, Villarejo-Balcells B, Olmos D et al (2014) JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Oncogene 33:1148–1157
39. Tonelli R, McIntyre A, Camerin C et al (2012) Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy. Clin Cancer Res 18:796–807
40. Jothi M, Mal AK (2012) Too much AKT turns PAX3-FKHR dead: a prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma. Oncotarget 3:1064–1065